학술논문

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
Document Type
Article
Source
In Neoplasia September 2017 19(9):661-671
Subject
Language
ISSN
1476-5586